Cusumano A M, Gonzalez Bedat M C, García-García G, Maury Fernandez S, Lugon J R, Poblete Badal H, Elgueta Miranda S, Gómez R, Cerdas Calderón M, Almaguer López M, Moscoso Tobar J, Leiva Merino R, Sánchez Polo Jv, Lou Meda R, Franco Acosta Bv, Ayala Ferrari R, Escudero E, Saavedra López A, Mena Castro E, Milanés Cl, Carlini R, Duro Garcia V
Clin Nephrol. 2010 Nov;74 Suppl 1:S3-8.
Between 1991 and 2006, the Latin American Dialysis and Renal Transplantation Registry collected data from 20 countries (Argentina, Brazil, Bolivia, Chile, Colombia, Costa Rica, Cuba, Ecuador, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Puerto Rico, Dominican Republic, Venezuela and Uruguay). Access to RRT was universal in Argentina, Brazil, Chile, Cuba, Puerto Rico, Venezuela and Uruguay, all countries belonging to the medium-high or high income group.
Data about patients on renal replacement therapy (RRT) were supplied by national affiliates or the Registry's Coordination Committee. Transplant data were gathered and shared with the Latin American and Caribbean Society of Transplantation.
RRT prevalence increased from 162 patients per million population (pmp) in 1991 to 478 pmp in 2005 and 473 pmp in 2006 (59.2% hemodialysis, 20.4% peritoneal dialysis and 20.4% with a functioning kidney allograft). Countries with the highest prevalence were Puerto Rico (1,148.9 pmp), Uruguay (924.5 pmp) and Chile (907.6 pmp). Latin America's (LA) incidence increased from 27.8 pmp in 1992 to 188 pmp in 2006. The LA Kidney transplant rate increased from 3.7 pmp in 1987 to 15,4 pmp in 2006, and 166 combined transplants - kidney and another organ, mainly pancreas - were performed. In the medium-high income group 2006, (Argentina, Brazil, Chile, Costa Rica, Cuba, Mexico, Panama, Uruguay, Venezuela) the prevalence rate was 534.8 pmp vs. 289.5 pmp in the middle-low income group. The transplant rate was 18.4 pmp in the medium-high income group vs. 7 pmp in the middle-low group (p < 0.01).
RRT incidence and prevalence continue to grow steadily. Access to RRT is universal only in some countries included in the medium-high or high income group. It is imperative to accomplish the goal of making RRT available to all who need it.
1991年至2006年间，拉丁美洲透析与肾移植登记处收集了来自20个国家（阿根廷、巴西、玻利维亚、智利、哥伦比亚、哥斯达黎加、古巴、厄瓜多尔、萨尔瓦多、危地马拉、洪都拉斯、墨西哥、尼加拉瓜、巴拿马、巴拉圭、秘鲁、波多黎各、多米尼加共和国、委内瑞拉和乌拉圭）的数据。在阿根廷、巴西、智利、古巴、波多黎各、委内瑞拉和乌拉圭，所有属于中高收入或高收入群体的国家，接受肾脏替代治疗（RRT）的机会是普遍存在的。
关于接受肾脏替代治疗（RRT）患者的数据由各国分支机构或登记处协调委员会提供。移植数据由拉丁美洲和加勒比移植协会收集并共享。
RRT的患病率从1991年的每百万人口162例患者（pmp）增加到2005年的478 pmp和2006年的473 pmp（血液透析占59.2%，腹膜透析占20.4%，有功能的同种异体肾移植占20.4%）。患病率最高的国家是波多黎各（1,148.9 pmp）、乌拉圭（924.5 pmp）和智利（907.6 pmp）。拉丁美洲（LA）的发病率从1992年的27.8 pmp增加到2006年的188 pmp。LA的肾脏移植率从1987年的3.7 pmp增加到2006年的15.4 pmp，并且进行了166例联合移植——肾脏和另一个器官，主要是胰腺。在2006年的中高收入群体（阿根廷、巴西、智利、哥斯达黎加、古巴、墨西哥、巴拿马、乌拉圭、委内瑞拉）中，患病率为534.8 pmp，而在中低收入群体中为289.5 pmp。中高收入群体的移植率为18.4 pmp，而中低收入群体为7 pmp（p < 0.01）。
RRT的发病率和患病率继续稳步增长。只有在中高收入或高收入群体中的一些国家，接受RRT的机会才是普遍存在的。必须实现让所有需要的人都能获得RRT的目标。
